Drug intelligence / Profile preview

Koldoff

Development stage: Unknown
Lead developer: AVN Ayurveda Formulations
Administration: Oral

Overview

Koldoff is an Ayurvedic polyherbal formulation developed by AVN Ayurveda Formulations for the management of allergies and infections of the upper respiratory tract. It is composed of aqueous extracts from several traditional medicinal plants, including Katphala (*Myrica nagi*), Kantakari (*Solanum xanthocarpum*), Kanaka (*Costus speciosus*), Nagara (*Zingiber officinale*), Pippali (*Piper longum*), Krishnajeeraka (*Nigella sativa*), and the Triphala components (Haritaki, Vibheetaki, and Amalaki). The formulation acts as an antiviral and antibacterial agent while providing immunity-boosting properties to combat respiratory conditions such as rhinitis, pharyngitis, sinusitis, adenoiditis, laryngitis, and tonsillitis.

Brand names: Koldoff
Other names: Koldoff Tablet

Beyond the preview

Go deeper on Koldoff.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Koldoff.

Explore the full profile